Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Dexras2 Activators

Dexras2 activators include a diverse set of chemical compounds that enhance the functional activity of Dexras2 through various specific biochemical pathways. S-Nitrosoglutathione and NOC-18 are nitric oxide donors that promote the S-nitrosylation of Dexras2, a post-translational modification known to activate this protein. Farnesyl Acetate and Prenylamine, by influencing the prenylation and calcium levels respectively, ensure proper membrane localization and activation of Dexras2, which is critical for its signaling functions. Similarly, GTPγS, as a non-hydrolysable GTP analog, binds to Dexras2, stabilizing its active conformation. The beta-adrenoceptor agonist Isoprenaline, by increasing cAMP levels, indirectly supports the activation of Dexras2 through PKA-mediated phosphorylation pathways.

On the other hand, Ionomycin and Thapsigargin manipulate intracellular calcium concentrations, a key regulator of Dexras2 activity, through their ionophoric action and SERCA inhibition, respectively. The use of cAMP analogs such as 8-Bromo-cAMP and N6-Benzoyl-cAMP also results in PKA activation, which leads to phosphorylation events that enhance the activity of Dexras2. Forskolin, by elevating cAMP levels via adenylate cyclase activation, creates a cellular environment conducive to Dexras2 activation via PKA. Nitrendipine, though primarily a calcium channel blocker, indirectly contributes to the complex calcium-dependent regulation of Dexras2 activity within the cell. Collectively, these chemical compounds facilitate the activation of Dexras2, leveraging its role in intracellular signaling without the necessity of modifying gene expression or direct ligand binding.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

S-Nitrosoglutathione (GSNO)

57564-91-7sc-200349
sc-200349B
sc-200349A
sc-200349C
10 mg
25 mg
50 mg
100 mg
$87.00
$210.00
$346.00
$449.00
15
(1)

S-Nitrosoglutathione directly donates NO groups, leading to S-nitrosylation of Dexras2, which is crucial for Dexras2 activation.

Farnesyl acetate

29548-30-9sc-235123
10 ml
$68.00
(0)

Farnesyl Acetate serves as a substrate for protein farnesyltransferase, leading to farnesylation and membrane association of Dexras2, enhancing its activity.

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$28.00
$38.00
5
(0)

Isoproterenol Hydrochloride, a beta-adrenoceptor agonist, increases cAMP levels, which can activate PKA and lead to phosphorylation that promotes Dexras2 activation.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Ionomycin acts as a calcium ionophore, increasing intracellular calcium levels that can enhance Dexras2 activation through calmodulin-dependent pathways.

8-Bromo-cAMP

76939-46-3sc-201564
sc-201564A
10 mg
50 mg
$126.00
$328.00
30
(1)

8-Bromo-cAMP is a cell-permeable cAMP analog, which activates PKA and can lead to the phosphorylation and activation of Dexras2.

Adenosine 3′,5′-cyclic Monophosphate, N6-Benzoyl-, Sodium Salt

30275-80-0sc-300167
10 µmol
$324.00
1
(1)

N6-Benzoyl-cAMP is another cAMP analog promoting PKA activation, which subsequently can enhance Dexras2 activity through phosphorylation.

Nitrendipine

39562-70-4sc-201466
sc-201466A
sc-201466B
50 mg
100 mg
500 mg
$109.00
$160.00
$458.00
6
(1)

Nitrendipine, a calcium channel blocker, indirectly enhances Dexras2 activity by altering calcium dynamics within the cell.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin activates adenylate cyclase, increasing intracellular cAMP and activating PKA, which then can enhance the activation of Dexras2.

NOC-18

146724-94-9sc-202247
sc-202247A
sc-202247B
sc-202247C
10 mg
50 mg
100 mg
500 mg
$51.00
$184.00
$305.00
$1122.00
18
(1)

NOC-18 acts as a nitric oxide donor, which can lead to the S-nitrosylation and activation of Dexras2.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased cytosolic calcium and potential activation of Dexras2-related pathways.